|The ALS2CR1 n/a (Catalog #MBS621961) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The ALS2CR1 (Amyotrophic Lateral Sclerosis 2 (juvenile) Chromosome Region, candidate 1, NIF3L1, NIF3 NGG1 interacting factor 3-like 1 (S. pombe), CALS-7, MDS015, NIF3 (Ngg1 interacting factor 3, S.pombe homolog)-like 1) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s ALS2CR1 can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).
Suitable for use in ELISA and Western Blot.
Dilution: ELISA: 1:50
Western Blot: 1:500. Researchers should empirically determine the suitability of the ALS2CR1 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The ALS2CR1 n/a product has the following accession number(s) (GI #12862478) (NCBI Accession #BAB32499.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Amyotrophic lateral sclerosis chromosomal region candidate gene protein 1 (ALSCR1) or NIF3-like protein1 is a 39kD cytoplasmic protein that participates in neuronal differentiation. The ALS2CR1 full-lengh transcrip is encoded within the ALS2 critical region, however, experimental evidences indicate that ALS2CR1 is not causative gene for amyotrophic lateral sclerosis (ALS20).
Immunogen: Synthetic peptide (ILSETDRDPLQVV) corresponding to aa338-350 of human ALS2CR1. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing ALS2CR1 are readily searchable from our website. Different antibodies against the same target such as ALS2CR1 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.